School of Medicine
Showing 101-150 of 214 Results
-
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
BioDr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now pending action for potential approval at the FDA. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of three FDA-approved drugs. He previously served as the Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health. -
Molly Timmerman
Clinical Assistant Professor (Affiliated), Orthopaedic Surgery
BioDr. Molly Timmerman is board-certified in Physical Medicine and Rehabilitation. She is Affiliated Clinical Assistant Professor of Physical Medicine and Rehabilitation/Orthopedic Surgery. She practices at Veterans Health Administration in Palo Alto, where she is Medical Director of Regional Amputation Center and the Polytrauma Network Site. She specializes in traumatic brain injury, post-traumatic headache management, and amputation medicine.
-
Alexander Tolas
Clinical Research Coordinator, Medicine - Med/Cardiovascular Medicine
BioI’m passionate about the many intersections between health, technology, and behavior. Specifically with how wearable devices and mobile technologies can be leveraged to measure and promote better health outcomes across all populations. After earning my BS in Kinesiology, I have formed a strong analytical background in wearable technology and health through my involvement in numerous clinical health studies and research projects. To supplement my interest, I have had multiple academic pieces accepted by Medicine & Science in Sports & Exercise (MSSE) and The Journal for the Measurement of Physical Behaviour (ISMPB).
-
Sarina Tom
Associate Director for Education Operations, Pediatrics
Current Role at StanfordEducation Operations Manager
Office of Pediatric Education
Stanford Department of Pediatrics -
Merve Topak Jamsran
Casual - Non-Exempt, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
Current Role at StanfordResearch Assistant
-
Caitlin Marie Toth
Assistant Clinical Research Coordinator, Emergency Medicine
Current Role at StanfordAssistant Clinical Research Coordinator
Stanford School of Medicine
Emergency Medicine Research -
Leonardo Tozzi
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioLeonardo Tozzi, M.D., Ph.D., graduated as a Medical Doctor from Pisa University and Sant'Anna School of Advanced Studies in 2013. In 2018, he was awarded his Ph.D. from Trinity College Dublin for his research on the impact of genetic risk factors, epigenetic modifications and environmental stressors on structural and functional brain changes related to depression.
Leonardo joined Stanford in 2018 as a post-doctoral researcher working within the framework of the Human Connectome Project. Since 2022, he leads the Computational Neuroscience & Neuroimaging Program at the Stanford Center for Precision Mental Health and Wellness.
The goal of Leonardo's research is to develop quantitative biomarkers for psychiatry that are reliable, interpretable and can be used to guide treatment selection and estimate therapy response. To this end, he integrates behavioral measures and symptoms with large scale recordings of brain structure and function as well as other biological markers.
In his free time, Leonardo enjoys practicing martial arts, playing video-games and road tripping around the USA.
